News

Check out market updates

FDA gives fast-track designation to Arca biopharma’s COVID treatment

WESTMINSTER — A potential therapy for severe COVID-19 patients being developed by Arca Biopharma Inc. (Nasdaq: ARCA) received a fast-track […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *

X